RecruitingNCT06494033
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients: a Single Center Prospective Study
Sponsor
University of Miami
Enrollment
100 participants
Start Date
Jul 3, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Inclusion Criteria3
- Adult patients over 18 years of age
- Lung transplant candidates with positive CMV IgG
- Anticipated to receive a lung transplant (both double lung and single lung)
Exclusion Criteria4
- Negative CMV IgG prior transplant
- Pregnant or breastfeeding women
- HIV infected patients
- Combined organ (e.g., lung-heart, lung-kidney) transplant candidates
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06494033
Related Trials
Respiratory Muscles and Work of Breathing in Children
NCT050512541 location
Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.
NCT055253121 location
Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study.
NCT059489041 location
Deep Functional Phenotyping of the ALA Lung Health Cohort
NCT0617771712 locations
Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients
NCT067287091 location